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Abstract. 
 
SUMO is a ubiquitin-related protein that 
functions as a posttranslational modiﬁcation on other 
proteins. SUMO conjugation is essential for viability in 
 
Saccharomyces cerevisiae
 
 and is required for entry into 
mitosis. We have found that SUMO is attached to the 
septins Cdc3, Cdc11, and Shs1/Sep7 speciﬁcally during 
mitosis, with conjugates appearing shortly before 
anaphase onset and disappearing abruptly at cytokine-
sis. Septins are components of a belt of 10-nm ﬁlaments 
encircling the yeast bud neck. Intriguingly, only septins 
on the mother cell side of the bud neck are sumoylated. 
We have identiﬁed four major SUMO attachment-site 
lysine residues in Cdc3, one in Cdc11, and two in Shs1, 
all within the consensus sequence (IVL)KX(ED). Mu-
tating these sites eliminated the vast majority of bud 
neck-associated SUMO, as well as the bulk of total 
SUMO conjugates in G
 
2
 
/M-arrested cells, indicating 
that sumoylated septins are the most abundant SUMO 
conjugates at this point in the cell cycle. This mutant has 
a striking defect in disassembly of septin rings, resulting 
in accumulation of septin rings marking previous divi-
sion sites. Thus, SUMO conjugation plays a role in regu-
lating septin ring dynamics during the cell cycle.
Key words: Smt3 • SUMO • septin • cytoskeleton • 
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P
 
OSTTRANSLATIONAL
 
 modifications of proteins play
critical roles in most cellular processes through their
unique ability to cause rapid alterations in the func-
tions of preexisting proteins, multiprotein complexes, and
subcellular structures. One recently discovered modifica-
tion involves the covalent attachment of the small ubiq-
uitin-related protein SUMO to other proteins. SUMO,
also known as sentrin or Ubl1 (Okura et al., 1996; Shen
 
et al., 1996), or in yeast as Smt3
 
1 
 
(Johnson et al., 1997), was
originally discovered attached to the Ran GTPase-activat-
ing protein, RanGAP1
 
2
 
 (Matunis et al., 1996; Mahajan et al.,
1997), and has subsequently been shown to be conjugated
to a rapidly growing set of substrates including I
 
k
 
B
 
a
 
, the
inflammatory response regulatory protein (Desterro et
al., 1998), and PML, a protein whose fusion to the retin-
oic acid receptor causes acute promyelocytic leukemia
(Sternsdorf et al., 1997; Kamitani et al., 1998b; Müller et al.,
1998). 
 
Saccharomyces cerevisiae
 
 cells deficient in SUMO
conjugation are inviable and arrest in the cell cycle before
anaphase (Seufert et al., 1995; Li and Hochstrasser, 1999).
Thus, SUMO conjugation is a key regulatory mechanism
in the growth control pathways of both yeast and higher
eukaryotes.
SUMO is 18% identical to ubiquitin (Ub), a highly con-
served 76-residue protein whose primary function is to tar-
get proteins for proteolysis, either by the 26S proteasome
or by endocytosis into the lysosome or yeast vacuole (re-
viewed by Hershko and Ciechanover, 1998). All known
functions of Ub involve its covalent attachment to other
proteins, usually via an isopeptide bond between Ub’s
COOH-terminal carboxyl group and the 
 
e
 
-amino group of
an internal Lys residue in the substrate. Proteins to be de-
graded by the proteasome are linked to a multi-Ub chain,
in which successive copies of Ub are attached to an inter-
nal Lys residue of the previous Ub in the chain. Ub conju-
gation is carried out in three enzymatic steps, catalyzed by
a Ub-activating enzyme (E1), one of a family of Ub-conju-
gating enzymes (E2s), and a Ub-protein ligase or recognin
(E3). Ub conjugation can also be reversed by a family of
deubiquitinating enzymes (Dubs) which cleave the isopep-
tide bond.
The SUMO and Ub conjugation pathways are entirely
distinct, but share multiple similarities. In the first step of
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1. We are calling the product of the 
 
Saccharomyces cerevisiae SMT3
 
 gene
SUMO to bring the yeast terminology for this modification in line with the
mammalian terminology.
2. 
 
Abbreviations used in this paper: 
 
GFP, green fluorescence protein;
HA, influenza virus hemagglutinin epitope tag; MALDI-TOF, matrix-
assisted laser desorption/ionization time of flight; NTA, nitriloacetic acid;
RanGAP1, Ran GTPase-activating protein; ts, temperature sensitive; Ub,
ubiquitin. 
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the SUMO conjugation pathway, SUMO is activated by a
heterodimeric activating enzyme (E1) consisting of Aos1
and Uba2, proteins with sequence similarity to the NH
 
2
 
and COOH terminus, respectively, of Ub activating en-
zymes (Johnson et al., 1997; Okuma et al., 1999). The sec-
ond enzyme in the SUMO pathway is Ubc9, a protein with
strong sequence similarity to Ub-conjugating enzymes
(E2s; Desterro et al., 1997; Gong et al., 1997; Johnson and
Blobel, 1997; Schwarz et al., 1998). There are also specific
proteases that cleave SUMO–substrate isopeptide bonds,
one of which is encoded by the yeast 
 
ULP1
 
 gene (Li and
Hochstrasser, 1999).
The function of SUMO conjugation is only beginning to
be understood. There are four well-characterized sub-
strates of mammalian SUMO: RanGAP1, I
 
k
 
B
 
a
 
, and two
components of so-called PML nuclear bodies, PML and
Sp100. In the cases of RanGAP1, Sp100, and PML,
SUMO conjugation functions by altering the subcellular
localization of its substrates. Attachment of SUMO targets
the otherwise cytosolic RanGAP1 to the nuclear pore
complex by promoting binding to Nup358/RanBP2 (Ma-
tunis et al., 1996; Mahajan et al., 1997), which is also
sumoylated (Saitoh et al., 1998), whereas SUMO conjuga-
tion to PML and Sp100 is involved in their tight localiza-
tion to the PML nuclear bodies (Sternsdorf et al., 1997;
Müller et al., 1998). SUMO has an entirely different effect
on I
 
k
 
B
 
a
 
, where it becomes attached to the major ubiquiti-
nation site, preventing ubiquitination and thereby protect-
ing sumoylated I
 
k
 
B
 
a
 
 from proteasome-dependent pro-
teolysis (Desterro et al., 1998). As SUMO is only distantly
related to Ub, it is very unlikely that SUMO itself targets
proteins for proteasome-dependent proteolysis.
In 
 
S
 
.
 
 cerevisiae
 
, SUMO is encoded by the 
 
SMT3
 
 gene,
which was originally isolated as a high-copy suppressor of
mutations in 
 
MIF2
 
, which encodes a centromere binding
protein (Meluh and Koshland, 1995). SUMO conjugation
is essential for yeast viability, as 
 
SMT3
 
, 
 
UBA2
 
, 
 
AOS1
 
,
 
UBC9
 
, and 
 
ULP1
 
 are all essential genes (Dohmen et al.,
1995; Seufert et al., 1995; Johnson et al., 1997; Li and
Hochstrasser, 1999). The pattern of SUMO conjugates
changes during the cell cycle (Li and Hochstrasser, 1999),
and conditional mutants in the SUMO conjugation path-
way arrest in the cell cycle after DNA replication, but be-
fore anaphase, with a short spindle and an undivided nu-
cleus positioned on the mother cell side of the bud neck
(Seufert et al., 1995; Li and Hochstrasser, 1999).
The yeast bud neck is a dynamic structure that is the fo-
cus of many processes involved in the polarized growth
and division of yeast cells. Its primary structural feature is
a belt of 10-nm filaments whose central components are
members of a family of GTP-binding coiled-coil proteins
called septins (reviewed by Longtine et al., 1996). Yeast
contain seven septin genes, of which two are expressed
only during sporulation, and five,
 
 CDC3
 
, 
 
CDC10
 
, 
 
CDC11
 
,
 
CDC12
 
, and 
 
SHS1/SEP7
 
, are expressed during vegetative
growth. A septin-containing ring initially forms in the
mother cell during G
 
1
 
, 
 
z
 
15 min before bud emergence.
After the bud appears, the ring extends into the bud, form-
ing a continuous hourglass-shaped structure that appears
as a “double ring.” During cytokinesis, the 10-nm filaments
visible by electron microscopy disappear, but the septin
ring, as visualized by immunofluorescence microscopy,
 
splits in half, and the remaining septin-containing struc-
tures are disassembled during the following G
 
1
 
 phase.
The septin ring acts as a scaffold for the binding of other
proteins (DeMarini et al., 1997). Proteins associated with
the septins include those involved in chitin deposition
(DeMarini et al., 1997), bud site selection (Chant et al.,
1995; Sanders and Herskowitz, 1996), mating projection
formation (Giot and Konopka, 1997), cytokinesis (Bi et al.,
1998; Lippincott and Li, 1998a,b), and a checkpoint that
monitors the presence of a septin ring before nuclear divi-
sion (Carroll et al., 1998; Longtine et al., 1998; Barral et al.,
1999). Septin mutations affect all of these functions. 
 
CDC3
 
and 
 
CDC12
 
 are strictly essential genes, whereas 
 
cdc10
 
 and
 
cdc11
 
 deletion strains are viable, but show severe defects
in septin-related processes, especially at high tempera-
tures. Mutants in 
 
SHS1
 
 display more subtle defects (Car-
roll et al., 1998; Mino et al., 1998). In conditional septin
mutants at the nonpermissive temperature, all septins fail
to localize to the bud neck, and cells develop multiple,
branched, highly elongated buds, become multinucleate,
and do not undergo cytokinesis.
As a first step toward understanding the physiological
role of the SUMO conjugation pathway in 
 
S
 
.
 
 cerevisiae
 
, we
were interested in identifying and characterizing substrate
proteins that become modified by SUMO. We discovered
that SUMO is attached to septins in a cell cycle-depen-
dent manner and have investigated the functional conse-
quences of impairing septin sumoylation.
 
Materials and Methods
 
Media and Genetic Techniques
 
Standard techniques were used (Ausubel et al., 1994). Rich yeast media,
containing either 2% glucose (YPD) or 2% galactose (YPG), and syn-
thetic yeast media were prepared as described (Sherman et al., 1986).
Strains were cured of 
 
URA3
 
-containing plasmids using 5-fluoroorotic acid
(PCR Inc.; Boeke et al., 1984). Cell cycle arrests were induced by incubat-
ing for 3 h with 10 
 
m
 
M 
 
a
 
-factor, 0.1 M hydroxyurea, or 15 
 
m
 
g/ml nocoda-
zole (Sigma Chemical Co.).
 
Plasmid Constructions
 
The pRS315-derived (Sikorski and Hieter, 1989) plasmid p315-P
 
GAL
 
-
HFSMT3, for expressing His6- and FLAG-tagged SUMO(G98) from
P
 
GAL10
 
, has been described (Johnson et al., 1997). p315-CDC3-HA was
pRS315-derived and contained 
 
z
 
1,000 bp of the 5
 
9
 
 flanking sequence of
 
CDC3
 
 and the 
 
CDC3
 
 coding region fused to a COOH-terminal influenza
virus hemagglutinin epitope tag (HA) sequence encoding GYPYDVP-
DYAAFL (Johnson et al., 1992). p315-CDC3-
 
D
 
94-HA lacked the coding
region for the NH
 
2
 
-terminal 94 residues of Cdc3, so that the expressed
protein began MSQING. p315-P
 
GAL
 
-CDC3-HA expressed full-length
Cdc3-HA from P
 
GAL10
 
. Plasmids expressing variants of Cdc3 with TEV
protease cleavage sites or Lys to Arg mutations were produced by oligo-
nucleotide-directed site-specific mutagenesis of p315-CDC3-HA using the
Mutagene kit (BioRad) according to the manufacturer’s instructions.
Single stranded p315-CDC3-HA was produced using helper phage
R408 (Promega Corp.). Partial protein sequences encoded by TEV site-
containing Cdc3 constructs, including the altered segment are as follow:
pCDC3-TEV-K2, RQH
 
21
 
ENLYFQGSD
 
26
 
VQI; pCDC3-TEV-K3, DGV
 
39
 
ENLYFQGSQ
 
48
 
NDD; pCDC3-TEV-K4, GLG
 
69
 
ENLYFQGSQ
 
76
 
SEK;
pCDC3-TEV-K6, IRRQ
 
95
 
ENLYFQGSI
 
96
 
NGY. Introduced sequence is
underlined. Superscripts indicate positions of amino acid residues in the
unaltered sequence. TEV protease cleaves between Gln and Gly in the in-
troduced sequence. Correctly mutagenized plasmids were identified by di-
gesting with BamHI, whose cleavage site encodes the Gly-Ser in the intro-
duced sequence. Plasmids containing Lys to Arg mutations in 
 
CDC3
 
 were
identified by cleaving with the following restriction enzymes: K4R, PstI; 
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K11R, BamHI; K30R, AatII; K63R, BsiWI; K415R,
 
 
 
BamHI; K443R,
MscI. All oligonucleotide sequences and construction details are available
on request.
 
Yeast Strains
 
S
 
.
 
 cerevisiae
 
 strains used are listed in Table I. Strains in which the genomic
copies of genes bear epitope tags, deletions, Lys to Arg mutations, or pre-
viously isolated mutant alleles, were produced by transforming yeast with
the products of assembly PCR reactions, made as follows, which were in-
tegrated into the chromosome by homologous recombination. Three PCR
products that overlapped by 17–20-bp were used as the templates in a sec-
ond round PCR reaction using outside primers to produce a product con-
taining the 5
 
9
 
 flanking sequence and/or the coding sequence of the gene of
interest, with or without a tag or a mutation, followed by a selective
marker and then the 3
 
9
 
 flanking sequence. Transformants were selected
for the appropriate selective marker and were screened further by immu-
noblotting with an mAb against the HA epitope, by amplifying the gene
of interest from chromosomal DNA and digesting with an appropriate re-
striction enzyme diagnostic for a point mutation, or by screening for the
desired temperature sensitive (ts) phenotype. Strains containing multiple
altered genes were derived from the single mutants by mating and tetrad
dissection. Chromosomal DNA derived from MY254 (a generous gift of
M. Yuste and F. Cross, Rockefeller University, NY, NY) and STX339-1C
(Yeast Genetic Stock Center) was used as source of the 
 
cdc15-2
 
 and
 
cdc12-1
 
 alleles, respectively. In constructing EJY309, the 
 
SHS1
 
 coding se-
quence was amplified in two overlapping pieces, one containing the
K426R mutation and the other containing the K437R mutation with a
BstBI restriction site included in the overlapping region between the two
mutations. Cdc12 with a COOH-terminal green fluorescent protein (GFP)
tag was constructed by inserting the 
 
CDC12
 
 coding sequence into
pYX242-GFP (Rosenblum et al., 1998). As the high level of Cdc12-GFP
expression produced from this plasmid was toxic to EJY318, but not to
wild-type cells, we integrated the GFP tag into one of the 
 
CDC12
 
 loci in
the diploids EJY318 and JD51, as described above, to produce EJY320
and EJY319, respectively. Cultures of EJY320 contained a greater pro-
portion of abnormal cells than either the parental strain EJY318 or the
wild-type control strain EJY319. All construction details and oligonucle-
otide sequences are available on request.
 
Antibodies
 
A rabbit polyclonal antibody was raised against NH
 
2
 
 terminally His
 
6
 
-
tagged SUMO(G98) (Cocalico Biologicals) and was affinity purified on a
His
 
6
 
-FLAG-SUMO(G98) affinity column (Johnson et al., 1997) as de-
scribed (Harlow and Lane, 1988). In a whole cell lysate from an arrested
 
ubc9
 
 mutant, the affinity-purified anti-SUMO antibody recognized only
free unconjugated SUMO (data not shown), demonstrating its specificity.
A rabbit polyclonal antibody against Cdc3, a generous gift of J. Pringle
(University of North Carolina, Chapel Hill, NC), was affinity purified on a
nitrocellulose filter containing Cdc3-lacZ (expressed from pUR-PH1
[Kim et al., 1991] a gift of J. Pringle) as described (Pringle et al., 1991).
The unpurified anti-Cdc3 serum recognized primarily an 
 
z
 
100-kD band
unrelated to Cdc3. The affinity-purified antibody also contained a small
amount of antibody against this other protein. Other antibodies used were
the 16B12 mAb against the HA epitope (in Figs. 1 b, 3, 4 b, 5 b, and 6;
Berkeley Antibody Co.), the 3F10 mAb against the HA epitope (in Fig.
2 a; Boehringer Mannheim Corp.), the B5-1-2 mAb against tubulin (a gen-
erous gift of Mike Rout, Rockefeller University, NY, NY), and a rabbit
polyclonal antibody against Cdc11 (Santa Cruz Biotechnology).
 
Immunoblot Analyses of Whole Yeast Lysates
and Immunoprecipitates
 
Yeast whole cell lysates were prepared as described (Yaffe and Schatz,
1984). Acetone-washed TCA precipitates were resuspended in 0.5 M Tris
 
Table I. S. cerevisiae Strains
 
Name Relevant genotype Source
 
DF5
 
MAT
 
a
 
/
 
MAT
 
a
 
 
 
trp1-1/trp1-1 ura3-52/ura3-52 his3-
 
D
 
200/his3-
 
D
 
200 leu2-3,112/leu2-3,112 lys2-801/lys2-801
 
Finley et al., 1987
YWO102*
 
‡
 
MAT
 
a
 
 
 
ubc9
 
D
 
::TRP1 leu2::ubc9Pro-Ser::LEU2
 
Seufert et al., 1995
EJY251-11b*
 
MAT
 
a
 
 
 
smt3
 
D
 
::HIS3
 
Johnson et al., 1997
EJY300*
 
MAT
 
a
 
 
 
cdc3
 
D
 
::HIS3
 
This study
JD51
 
MAT
 
a
 
/
 
MAT
 
a
 
 
 
trp1
 
-
 
D
 
1/trp1-
 
D
 
1 ura3-52/ura3-52 his3-
 
D
 
200/his3-
 
D
 
200 leu2-3,112/leu2-3,112 lys2-801/lys2-801
 
Dohmen et al., 1995
JD52
 
§
 
MAT
 
a
 
J. Dohmen
(Heinrich-Heine-
Universität, Düs-
seldorf, Germany)
EJY301
 
§
 
MAT
 
a
 
 
 
CDC3-HA::HIS3
 
This study
EJY302
 
§
 
MAT
 
a
 
 
 
CDC10-HA::HIS3
 
This study
EJY303
 
§
 
MAT
 
a
 
 
 
CDC11-HA::HIS3
 
This study
EJY304
 
§
 
MAT
 
a
 
 
 
CDC12-HA::HIS3
 
This study
EJY305
 
§
 
MAT
 
a
 
 
 
SHS1-HA::HIS3
 
This study
EJY306
 
§
 
MAT
 
a
 
/
 
MAT
 
a
 
 
 
CDC3-HA::HIS3/CDC-HA::HIS3
 
This study
EJY307
 
§
 
MATa cdc3-D94-HA::TRP1 This study
EJY308§ MATa cdc11-R412-HA::HIS3 This study
EJY309§ MATa shs1-R426,437-HA::HIS3 This study
EJY310§ MATa cdc3-D94-HA::TRP1 cdc11-R412-HA::HIS3 This study
EJY311§ MATa cdc3-D94-HA::TRP1 cdc11-R412-HA::HIS3 shs1-R426,437-HA::HIS3 This study
EJY312§ MATa cdc3-R4,11,30,63-HA::TRP1 This study
EJY316§ MATa cdc3-R4,11,30,63-HA::TRP1 cdc11-R412-HA::HIS3 shs1-R426,437-HA::HIS3 This study
EJY318§ MATa/MATa cdc3-R4,11,30,63-HA::TRP1/cdc3-R4,11,30,63-HA::TRP1 This study
 cdc11-R412-HA::HIS3/cdc11-R412-HA::HIS3 shs1-R426,437-HA::HIS3/shs1-R426,437-HA::HIS3
EJY319§ MATa/MATa CDC12-GFP::URA3/CDC12 This study
EJY320§ MATa/MATa cdc3-R4,11,30,63-HA::TRP1/cdc3-R4,11,30,63-HA::TRP1 This study
cdc11-R412-HA::HIS3/cdc11-R412-HA::HIS3 shs1-R426,437-HA::HIS3/shs1-R426,437-HA::HIS3
CDC12-GFP::URA3/CDC12
EJY321§ MATa cdc15-2::URA3 This study
EJY322§ MATa CDC3-HA::HIS3 cdc15-2::URA3 This study
EJY323§ MATa cdc3-R4,11,30,63-HA::TRP1 cdc12-1::TRP1 This study
*Derived from DF5.
‡Our isolate appears to be disomic for Chr III including the leu2::ubc9Pro-Ser::LEU2 allele.
§Derived from JD51.The Journal of Cell Biology, Volume 147, 1999 984
base, 6.5% SDS, 100 mM dithiothreitol (DTT), and 12% glycerol, heated
at 658C for 20 min and the debris removed by microcentrifugation. Ly-
sates were subjected to immunoblotting, followed by chemiluminescent
detection as described (Johnson et al., 1997). For anti–HA-epitope immu-
noprecipitations, 45 ml of lysate (z1 mg protein) was added to 1.5 ml
RIPA buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 5 mM EDTA, 1% Tri-
ton X-100) containing 2 mg/ml of each of the protease inhibitors antipain,
aprotinin, chymostatin, leupeptin, and pepstatin, plus 50 mM N-ethylma-
leimide (Sigma Chemical Co.). 10 ml of anti-HA–Sepharose (Berkeley An-
tibody Co.) was added, followed by incubation at 48C for 2 h with rotation.
Beads were washed three times with RIPA buffer plus 0.1% SDS, resus-
pended in Laemmli loading buffer lacking reducing agent, and incubated
at 658C for 20 min. The supernatant was removed, supplemented to 100 mM
DTT, and analyzed by SDS-PAGE and immunoblotting as described.
For the TEV protease cleavage experiment, washed HA–Sepharose
beads bearing Cdc3-HA variants were washed once with 50 mM Tris, pH
8.0, 0.5 mM EDTA, and 1% Triton X-100, and incubated with 20 U TEV
protease (Life Technologies) for 4 h at 258C in 20 ml of the same buffer.
HA-Sepharose beads were pelleted by centrifugation, and the superna-
tant “unbound” fraction was removed. One 20 ml wash of the beads with
RIPA buffer and 0.1% SDS was added to the unbound fraction, and the
beads were washed three times with 1 ml RIPA buffer and 0.1% SDS and
prepared for SDS-PAGE as described above to yield the “bound” fraction.
Isolation of SUMO-conjugated Proteins
EJY251-11b containing p315-PGAL-HFSMT3 was grown at 308C in 4 liter
of YP containing 2% raffinose and 1% galactose to an A600 of 2. Cells
were harvested by centrifugation and lysed 10 min on ice in 200 ml cold
1.85 NaOH, 7.5% b-mercaptoethanol. Protein was precipitated by addi-
tion of 200 ml 50% TCA, collected by centrifugation, and the pellet was
washed with 200 ml ice-cold acetone. The pellet was resuspended in 400 ml
Buffer A (6 M guanidine HCl, 100 mM sodium phosphate, 10 mM Tris/
HCl, pH 8.0) and incubated at 258C for 1 h with rotating. Lysates were
clarified by centrifugation at 27,000 gmax, adjusted to pH z7.0 (measured
using pH paper) with 1 M Tris base, supplemented to 20 mM imidazole,
and bound in batch for 2 h to 2 ml of Ni-nitriloacetic acid (NTA) agarose
(Qiagen). The Ni-NTA agarose was loaded into a column, washed with 20 ml
of Buffer A, and then with 100 ml of Buffer B (8 M urea, 100 mM sodium
phosphate, 10 mM Tris, pH 6.3), and then eluted with 200 mM imidazole
in Buffer B. 4 ml of the eluate was added to 46 ml RIPA buffer containing
0.1% SDS, 1 mM PMSF, and 1 mM b-mercaptoethanol, and bound in
batch overnight at 48C to 0.4 ml anti-FLAG sepharose (IBI/Kodak). The
anti-FLAG Sepharose was loaded into a column, washed with 50 ml of
RIPA buffer with 0.1% SDS, and then eluted with 100 mM glycine, pH
2.2, 150 mM NaCl, 1% Triton X-100, and 0.1% SDS. The eluate was frac-
tionated on a 5–20% acrylamide gel. Protein bands detected by staining
with Coomassie brilliant blue were excised and identified by direct analy-
sis of a Lys-C endoproteinase digest by matrix-assisted laser desorption/
ionization time of flight (MALDI-TOF) mass spectrometry at the Rocke-
feller University Protein/DNA Technology Center (NY, NY) as described
(Gharahdaghi et al., 1996). Two different bands yielded fragments of
1032.6, 1226.6, 1274.8, 1356.2, 1607.9, 1844.6, 1995.86, 2268.5, and
3574.5 D, which match the masses predicted by a theoretical digest of
Cdc3. Some of the other bands identified contained other sumoylated pro-
teins, but many contained proteins that bound nonspecifically to the affin-
ity columns.
Fluorescence Microscopy
Yeast cells were prepared for indirect immunofluorescence microscopy
essentially as described (Pringle et al., 1991). Cells were fixed in 3.7%
formaldehyde for 10 min. Proteins were visualized by incubating with the
primary antibodies described above, followed by Cy3-conjugated donkey
anti–rabbit IgG or fluorescein (DTAF)-conjugated donkey anti–mouse
IgG (Jackson Laboratories). Cells were mounted in 49,6-diamidino-2-phe-
nylindole (DAPI)-containing medium to visualize DNA. GFP fluores-
cence and Calcofluor staining of bud scars were visualized in live yeast
stained with Fluorescent Brightener 28 (Calcofluor white; Sigma Chemi-
cal Co.) as described (Pringle, 1991). All micrographs were taken using a
633 oil objective on a Axiophot microscope (Carl Zeiss). Images were
transferred directly to Adobe Photoshop 3.05 using a Sony DKC-5000 dig-
ital photo camera. Overlaying of Cy3 and fluorescein signals in double-
label immunofluorescence microscopy experiments was done in Adobe
Photoshop.
Results
Septins Are Modified by SUMO during Mitosis
To identify substrates of the SUMO pathway, we con-
structed a strain that expressed His6- and FLAG-tagged
SUMO as its only copy of the SUMO-encoding SMT3
gene. When proteins bearing both tags were purified by af-
finity chromatography, the resulting fraction contained a
smear of high molecular weight bands (Fig. 1 a), similar to
the previously observed pattern of SUMO conjugates in
yeast (Johnson et al., 1997; Li and Hochstrasser, 1999).
Two of these bands were identified by direct mass spectro-
metric analysis of a protease digestion mixture (see Mate-
rials and Methods) as containing the product of the S. cere-
visiae CDC3 gene.
To confirm that Cdc3 could be modified by SUMO and
to ask whether any of the other four yeast septins ex-
pressed during vegetative growth were sumoylated, we
tagged the genomic copies of the CDC3, CDC10, CDC11,
CDC12, and SHS1 genes with the HA epitope tag (Field
et al., 1988). The HA-tagged versions of all five septins
were functional and were incorporated normally into the
septin ring at the bud neck (not shown). When these
strains were treated with nocodazole (see below), signifi-
cant amounts of higher molecular weight forms of Cdc3,
Cdc11, and Shs1 were observed, whereas Cdc10 and
Cdc12 were present only as single species of the predicted
molecular weight (Fig. 1 b, lanes 1–5). Immunoprecipita-
tion of the HA-tagged septins and immunoblotting with a
polyclonal antibody against SUMO confirmed that all of
the high molecular weight species of Cdc3, Cdc11, and
Shs1 contained SUMO (Fig. 1 b, lanes 6–10).
To test whether septin sumoylation is cell cycle depen-
Figure 1. SUMO is attached to the septins Cdc3, Cdc11, and
Shs1. a, Lysate from cells expressing His6- and FLAG epitope-
tagged SUMO was subjected to affinity chromatography on Ni-
NTA agarose and anti-FLAG agarose. The resulting fraction was
analyzed by SDS-PAGE and Coomassie brilliant blue staining.
Bands determined to contain Cdc3 by MALDI-TOF mass spec-
trometry are indicated by arrows. b, Whole cell lysates (lanes 1–5)
or anti-HA immunoprecipitates (lanes 6–10) from nocodazole-
arrested cells expressing HA-tagged septins were analyzed by
SDS-PAGE and immunoblotting with an mAb against the HA
epitope (lanes 1–5) or with a polyclonal antibody against SUMO
(lanes 6–10). Lanes 1 and 6, EJY301; lanes 2 and 7, EJY303; lanes
3 and 8, EJY305; lanes 4 and 9, EJY302; lanes 5 and 10, EJY304.
The HA-tagged septin in each lane is indicated. Bands corre-
sponding to unmodified HA-tagged septins are indicated.Johnson and Blobel SUMO Conjugation to Yeast Septins 985
dent, cells expressing Cdc3-HA were arrested in G1 with
the mating pheromone a-factor, in the S phase checkpoint
with hydroxyurea, in the G2/M spindle checkpoint with no-
codazole, or in late anaphase with the ts cdc15-2 allele. In
all cases, .90% of cells were arrested at the appropriate
point in the cell cycle (data not shown). Both Cdc3-HA
and Cdc11 were most heavily modified in nocodazole-
arrested cells and somewhat less so in cdc15-arrested cells
(Fig. 2 a). Very little, if any, of either septin was modified
in a-factor- or hydroxyurea-arrested cells, although the re-
sults were partially obscured by cross-reacting bands.
To define the stages when septins are sumoylated in
more detail, SUMO was visualized by double label immu-
nofluorescence microscopy. The protein detected in addi-
tion to SUMO was either Cdc3-HA (Fig. 3) or tubulin
(Fig. 2 b), whose localization was used to determine the
stage of the cell cycle occupied by individual cells. SUMO
localized to the nucleus at all points in the cell cycle (Fig.
3, a, e, j, and o; data not shown), but more strikingly it lo-
calized to a ring at the bud neck only during mitosis. Spe-
cifically, a ring of SUMO appeared at the bud neck of
large budded cells just before initiation of anaphase spin-
dle elongation and nuclear division (Figs. 2 b and 3 e). This
SUMO ring persisted through anaphase (Figs. 2 b and 3 j)
and it disappeared abruptly at cytokinesis, virtually simul-
taneously with septin ring separation (Fig. 3, o and p) and
the beginning of spindle breakdown (Fig. 2 b). Surpris-
ingly, the SUMO ring did not completely colocalize with
the septins. SUMO coincided only with the mother cell
side of the septin “double ring,” appearing on the side next
to the undivided nucleus or on the side of the larger cell in
mitotic cells (Fig. 3, e, i, j, and n). Thus, SUMO conjuga-
tion to the septins was asymmetrical with respect to the
mother–bud axis.
Identification of the SUMO Attachment Sites in Cdc3
To determine the function of septin sumoylation, we
wanted to generate yeast mutants in which septins would
not be modified. The most direct way to eliminate septin
sumoylation specifically was to identify the Lys residues
that serve as SUMO attachment sites and to replace them
with Arg residues, which cannot be modified, thereby
eliminating septin sumoylation without disturbing conju-
gation to other substrates.
Our initial approach to identifying SUMO attachment
sites on Cdc3 was to affinity-purify SUMO-Cdc3 conju-
gates from strains expressing Cdc3-HA and His6- and
FLAG-tagged SUMO(G98) or SUMO(A98). These prep-
arations varied only in the identity of the COOH-terminal
residue of SUMO, which is the residue involved in the
isopeptide bond with the substrate. This material was di-
gested with trypsin and with endoproteinase Lys C and an-
alyzed by MALDI-TOF mass spectrometry with the goal
of identifying species varying by the 14 mass unit differ-
ence between the COOH-terminal Gly and Ala in the two
preparations. One such species was identified, with a mo-
lecular weight of 2,327 D, which was consistent with
SUMO attachment at Lys11 of Cdc3 (data not shown).
Examination of the sequence surrounding Lys11 re-
vealed that three other Lys residues in the NH2-terminal
domain of Cdc3 were embedded in similar sequence mo-
tifs having the consensus (IVL)KXE, which appeared to
be a potential sumoylation site consensus sequence. Since
there are multiple SUMO-Cdc3 conjugate bands (Fig. 1),
such a consensus sequence might be used in either of two
different ways. SUMO might be attached at one or the
other of these Lys residues as a chain containing SUMO–
SUMO linkages, analogous to the multi-Ub chain. Alterna-
tively, multiple single copies of SUMO might be attached
with one SUMO moiety per Lys residue. To distinguish
between these possibilities, we designed a series of con-
structs containing cleavage sites for the TEV protease at
different sites along the NH2-terminal domain of Cdc3, ei-
ther after the first two Lys residues (TEV-K2), after the
third (TEV-K3), after the fourth (TEV-K4), or after the sixth
(TEV-K6; see Fig. 4 a). These constructs also contained a
COOH-terminal HA tag, which was used to immunopre-
cipitate the Cdc3 variants from lysates of nocodazole-
arrested yeast. Immunoprecipitated proteins were cleaved
with TEV protease while still bound to the beads and sep-
arated into an unbound fraction containing the fragment
NH2-terminal to the cleavage site, and a bound fraction
containing the COOH-terminal cleavage product. This ex-
periment showed that for each additional Lys residue
included NH2-terminal to the TEV site, an additional
sumoylated species appeared on the NH2-terminal prod-
uct and disappeared from the COOH-terminal product.
There was one major NH2-terminal SUMO-containing
Figure 2. Cell-cycle dependent attachment of SUMO to the sep-
tins. a, Whole cell lysates from EJY301 (CDC3-HA), growing ex-
ponentially (log) or arrested with a-factor, hydroxyurea (HU), or
nocodazole (NOC), or from EJY322 (CDC3-HA cdc15-2) that
had been arrested at 378C for 3 h (cdc15), were analyzed by SDS-
PAGE and immunoblotting with an mAb against the HA
epitope (top) or a polyclonal antibody against Cdc11 (bottom).
Bands corresponding to unmodified Cdc3-HA and to Cdc11 are
indicated. Arrows indicate the positions of SUMO-modified spe-
cies. Circles indicate bands that cross-react with the anti-HA an-
tibody. b, Exponentially growing wild-type (DF5) cells were ana-
lyzed by double-label immunofluorescence microscopy with a
polyclonal antibody against SUMO and an mAb against tubulin.
Height of bars represents the percentage of total cells in each of
the five categories illustrated below the histogram: unbudded
cells, small-budded cells (buds less than one third the size of the
mother cell), large-budded cells with a short spindle, cells under-
going nuclear division with an intact elongated spindle, and cells
with a divided nucleus and broken spindle. Black bars represent
the portion containing a SUMO ring at the bud neck. 424 total
cells were counted.The Journal of Cell Biology, Volume 147, 1999 986
species from TEV-K2, two from TEV-K3, and three from
TEV-K4 and TEV-K6 (Fig. 4 e), and there were two ma-
jor SUMO-containing COOH-terminal cleavage products
from TEV-K2, one from TEV-K3, and none from TEV-
K4 or TEV-K6 (Fig. 4 d, cleavage products are indicated;
lanes 2, 3, and 5 contained uncleaved species, see Fig. 4 b).
These results were generally consistent with a model
where single copies of SUMO are attached to Cdc3 at
three to four major sites, at Lys-4 and/or Lys-11, at Lys-30,
and at Lys-63. A separate experiment in which these Lys
residues were altered by site-directed mutagenesis showed
that both Lys-4 and Lys-11 can serve as sumoylation sites
(data not shown).
However, this model does not completely explain the
pattern of high molecular weight SUMO conjugates on
Cdc3, which consisted of seven bands between z95 and
z200 kD (Fig. 4 c, lanes 1–5). For several reasons, it is
more likely that the additional bands reflect the presence
of another mobility-altering factor, rather than attachment
of multiple copies of SUMO at the same Lys residue. One
is that cleavage at the TEV-K2 site produced only two
detectable SUMO-containing COOH-terminal fragments
(Fig. 4 d, lane 2). This result can be explained most easily
if a single mobility-altering factor lies NH2-terminal to the
TEV site at position 27. Once the NH2 terminus is cleaved
off, the number of bands associated with the COOH-ter-
minal fragment would reflect the number of attached
SUMO moieties, whereas NH2-terminal fragments would
still be present in two forms for every SUMO moiety. This
explanation is also consistent with the pattern of NH2-ter-
minal cleavage products, where there is a minor band
above each of the three major SUMO-containing bands
from TEV-K4 and TEV-K6 (Fig. 4 e, lanes 4 and 5). A sec-
ond reason is that several of the SUMO-Cdc3 bands and
corresponding NH2-terminal TEV cleavage product bands
appear to be too close together to differ by a whole
SUMO moiety. Free SUMO runs at z20 kD on SDS-
PAGE, but two of the pairs of SUMO-Cdc3 bands ap-
peared to differ by significantly less than 20 kD, and the
first two sets of major and minor NH2-terminal cleavage
products appeared to differ by 10 kD or less (Fig. 4 c, lane
1, and e, lanes 4 and 5). A third reason is that the TEV-K4
variant significantly reduced the amount of the third
SUMO-containing conjugate with a proportionate in-
crease in the second band, but there was no reduction in
intensity or change in position of the fourth or sixth
SUMO-containing bands (Fig. 4 c, lane 4, cf lanes 1–3, and
5). This result is most easily explained if the TEV-K4 mu-
Figure 3. SUMO localizes to the mother cell side of the septin ring during mitosis. Double-label immunofluorescence microscopy of
EJY306 (CDC3-HA/CDC3-HA) using a polyclonal antibody against SUMO (red; a, e, j, and o) and an mAb against the HA epitope
(green; b, f, k, and p). Cells were visualized by differential interference contrast (DIC; d, h, m, and r) and DNA by DAPI staining (c, g,
l, and q). Panels i and n are overlays of the anti-SUMO and anti-HA signals in the fields shown in e–h and j–m, respectively. Colocalization
is represented by yellow in the overlays. Bars, 5 mm.Johnson and Blobel SUMO Conjugation to Yeast Septins 987
tation reduced the other mobility-altering factor without
affecting SUMO conjugation. We do not know what this
other factor is. It might be another posttranslational modi-
fication, but it is also possible that conjugates bearing the
same number of SUMO moieties could have different mo-
bilities resulting from SUMO attachment at different sites.
Mutational Analysis of Sumoylation Site Lys Residues 
on Septins
Inspection of the Cdc11 and Shs1 sequences for sumoyla-
tion site consensus sequences revealed that Cdc11 con-
tained one such sequence near its COOH terminus and
that Shs1 contained two such sequences in its COOH-ter-
minal coiled-coil domain (Fig. 5 a). To determine the ef-
fects of eliminating these Lys residues on septin sumoyla-
tion and on cellular function, we made yeast strains in
which the genomic copies of septins were replaced with
mutant versions lacking these Lys residues. Deleting the
coding sequence for the 94 NH2-terminal residues of Cdc3
eliminated the vast majority of the SUMO-Cdc3 conju-
gates in nocodazole-arrested cells, confirming the conclu-
sion that most SUMO is attached to this NH2-terminal do-
main (Fig. 5 b, lanes 1 and 2). However, Cdc3-D94 was still
sumoylated at a very low level by one copy of SUMO (Fig.
5 b, lane 2; note the band running at the position of full-
length Cdc3-HA). This result was confirmed by immuno-
precipitating with the anti-HA antibody and immunoblot-
ting with an antibody against SUMO (data not shown).
Mutating two more Lys residues in CDC3-D94, Lys-415 in
the sequence IKQD, and Lys-443 in the sequence AKLE,
had no effect on this residual sumoylation (data not
shown). The only other sequence in Cdc3 that resembles
the sumoylation site consensus sequence is the AKSD
containing Lys-287, which is in the septin homology do-
main. This Lys residue is conserved in all members of the
septin family in all organisms, except for Shs1 and one hy-
pothetical open reading frame in S. pombe. Mutant cdc3
containing a Lys to Arg mutation in this position was un-
able to complement the lethality of the cdc3D strain, even
when all the NH2-terminal sumoylation site Lys residues
were present (data not shown). It is likely that this result
reflects a requirement for this Lys residue in some septin
function other than SUMO conjugation. When we mu-
tated Lys-412 of Cdc11, and Lys-426 and Lys-437 of Shs1
to Arg, similar results were observed. In both cases, the
vast majority of SUMO conjugates were eliminated, but a
small amount of residual conjugation remained, reflecting
low levels of SUMO conjugation at other sites (Fig 5 b,
lanes 3–6; data not shown).
As all of the strains with sumoylation site mutations in
only one of the septins still contained substantial SUMO
rings at the bud neck, we proceeded to construct a triple
mutant in which all of Cdc3, Cdc11, and Shs1 lacked the
major sumoylation sites. Analysis of a series of strains in
which progressively fewer septins contained sumoylation
sites demonstrated that the majority of the total SUMO in
nocodazole-arrested cells was attached to Cdc3 (Fig. 5 c,
lane 2, cf lane 1) and that the most of the remainder was
attached to Cdc11 or Shs1 (Fig. 5 c, lanes 2–4). Thus, sep-
tins are by far the most abundant SUMO conjugates at this
point in the cell cycle. However, a longer exposure of this
blot revealed a large number of lower abundance sub-
strates in the triple mutant strain (data not shown).
To minimize any non-SUMO–related effects from delet-
ing the entire Cdc3 NH2-terminal domain, we constructed
a different cdc3 sumoylation site mutant in which all four
attachment site Lys residues were replaced with Arg. This
mutant’s effects on Cdc3 sumoylation were indistinguish-
able from those of the deletion mutant (data not shown),
Figure 4. Single SUMO moieties are at-
tached to multiple Lys residues in the NH2-
terminal domain of Cdc3. a, Diagram of TEV
protease cleavage site-containing constructs,
showing the six Lys residues in the NH2-ter-
minal domain of Cdc3 and the positions of in-
troduced TEV cleavage sites. b–e, Exponen-
tial cultures of EJY300 (cdc3D) bearing
plasmids expressing Cdc3-HA or one of the
TEV site-containing Cdc3-HA constructs
were arrested with nocodazole, lysed, and the
lysates immunoprecipitated with an mAb
against the HA epitope. Immunoprecipitated
protein was treated with TEV protease while
bound to the beads, and the resulting cleav-
age products were separated into an unbound
fraction (e) and a bound fraction (b and d).
The uncleaved proteins are shown in c. Frac-
tions were analyzed by SDS-PAGE and im-
munoblotting with an mAb against the HA
epitope (b) or a polyclonal antibody against
SUMO (c–e). Lanes are numbered according
to construct numbers in a. Asterisks indicate
bands containing IgG. Arrow indicates un-
cleaved, unmodified Cdc3-HA. Open circles
in d indicate the TEV cleavage products.The Journal of Cell Biology, Volume 147, 1999 988
and subsequent experiments were done using this cdc3 al-
lele. We analyzed the sumoylation site triple mutant (cdc3-
R4,11,30,63 cdc11-R412 shs1-R426,437) for phenotypes
and found that in most respects it was very similar to the
parental wild-type strain. Its growth rate was virtually
indistinguishable from that of the wild-type (data not
shown), with a doubling time of 95 min, versus 94 min for
wild-type, a statistically insignificant difference. This strain
was not hypersensitive to either high or low temperatures,
to 1 M sorbitol, to DNA damaging agents (UV light or
methyl methane sulfonate), to the microtubule depolymeriz-
ing drug benomyl, or to the cell wall perturbing agent Cal-
cofluor white (data not shown). It mated efficiently and
sporulated with the same efficiency as wild-type to pro-
duce viable segregants (data not shown). Haploid cells
correctly positioned their bud sites axially, and most dip-
loid cells positioned their bud sites bipolarly, although
both this strain and the parental wild-type diploid strain
had a significant frequency of cells with random bud sites
(data not shown). The actin cytoskeleton, as visualized by
rhodamine-phalloidin staining, also appeared normal in
the triple mutant (data not shown).
We also analyzed the triple mutant by double-label
immunofluorescence microscopy with antibodies against
SUMO and against the HA tag on the septins. The triple
mutant displayed a dramatic reduction in SUMO staining
at the bud neck (Fig. 6, a–h), although a faint ring could be
seen in a few cells (data not shown), and other cells con-
tained a bulge of SUMO staining at the bud neck near the
nuclear envelope that did not appear to colocalize com-
pletely with the mother cell half of the septin ring (Fig. 6 e).
This slight SUMO localization to the bud neck probably
Figure 5. Mutational analysis of SUMO at-
tachment site Lys residues in the septins. a,
Sequences surrounding SUMO attachment
sites in the septins. b and c, Whole cell lysates
from nocodazole-arrested cultures were ana-
lyzed by SDS-PAGE and immunoblotting
with an mAb against the HA epitope (b), or a
polyclonal antibody against SUMO (c). b,
Lane 1, EJY301; lane 2, EJY307; lane 3,
EJY303; lane 4, EJY308; lane 5, EJY305; lane
6, EJY309. The HA-tagged septin in each
strain is indicated over the lane. c, Lane 1,
JD52 (wild-type); lane 2, EJY307 (cdc3-D94-
HA); lane 3, EJY310 (cdc3-D94-HA cdc11-
R412-HA), lane 4, EJY311 (cdc3-D94-HA
cdc11-R412-HA shs1-R426,437-HA).
Figure 6. The triple sumoyla-
tion site septin mutant ac-
cumulates extra septin rings.
a–h, EJY306 (CDC3-HA; a
and b) or EJY318 (cdc3-
R4,11,30,63  cdc11-R412-
HA shs1-R426,437-HA; c–h)
were analyzed by double-
label immunofluorescence
microscopy with a polyclonal
antibody against SUMO (a, c,
e, and f) and an mAb against
the HA epitope (b, d, g, and
h). i–n, Fluorescence micros-
copy of living log phase cells
stained with Calcofluor, visu-
alizing Calcofluor staining (i,
k, and m) or Cdc12-GFP (j, l,
and n). Strains used were
EJY319 (CDC12-GFP; i and
j) and EJY320 (cdc3-
R4,11,30,63  cdc11-R412-HA
shs1-R426,437-HA CDC12-
GFP;  k–n). Arrowheads indi-
cate septin rings remaining
from previous cell cycles.
Bars, 5 mm.Johnson and Blobel SUMO Conjugation to Yeast Septins 989
resulted from the residual sumoylation of the septins, al-
though some other bud neck protein may also be sumoy-
lated at a very low level.
The striking difference that we noted between the triple
mutant strain and wild-type was that in the mutant, at least
one extra septin ring could be observed in virtually all
budded cells (Fig. 6, d, g, and h). This is in contrast to the
wild-type strain, in which budded cells never contained
septin rings other than at the neck of the growing bud (Fig.
6 b). The presence of these extra septin rings was a syn-
thetic phenotype of the triple mutant, as none of the single
mutants or the cdc11-R412 shs1-R426,437 double mutant
had this property (data not shown). To test the hypothesis
that the extra septin rings in the triple mutant were rem-
nants of septin rings from previous cells divisions, we com-
pared the localization of the extra septin rings with that of
the bud scars. Every time an S. cerevisiae cell divides, the
division site on the mother cell is marked by a chitin-con-
taining bud scar, stainable with the fluorescent dye Calco-
fluor white, which persists through the lifetime of the cell.
Although they sometimes had many bud scars, wild-type
budded cells never contained more than the one septin
ring at the base of the growing bud (Fig. 6, i and j). In the
mutant, however, a septin ring colocalized with virtually
every bud scar (Fig. 6, k and l), indicating that the extra
septin rings are likely to be undisassembled septin rings
from previous bud sites. Unlike mother cells, daughter
cells do not have Calcofluor-staining structures marking
the division site. Examination of budded cells lacking bud
scars revealed that they always contained exactly one ex-
tra septin ring, indicating that daughter cells are also de-
fective in septin ring disassembly (Fig. 6, m and n).
There are two simple reasons why the triple sumoyla-
tion site mutant might be defective in septin ring disassem-
bly. One is that attachment of SUMO to the septin ring
promotes disassembly. The other is that the sumoylation-
site Lys residues also have some other function, and that
this other function promotes septin ring disassembly. For
example, the purpose of these Lys residues could be to
serve as ubiquitination sites, or perhaps acetylation or
methylation sites. One way to distinguish between these
possibilities might be to determine whether mutants in the
SUMO conjugation pathway also have septin ring disas-
sembly defects. Examination of Cdc11 localization in ubc9
(Fig. 7 a) and uba2 (data not shown) ts mutants showed
that no extra septin rings were visible in cells from either
strain, either when grown at the permissive temperature or
after transfer to the restrictive temperature. This result
may suggest that SUMO conjugation, per se, does not pro-
mote septin ring disassembly. Alternatively, it may indi-
cate that, although SUMO conjugation may promote sep-
tin ring disassembly, as long as these  ts mutants retain
enough SUMO conjugating activity to divide, they also re-
tain sufficient SUMO conjugation to disassemble their
septin rings.
In contrast to a previously published report (Takahashi
et al., 1999), the levels of Cdc3 and Cdc11 did not decrease
noticeably when the ubc9 ts mutant was incubated at the
nonpermissive temperature for 4 h (Fig. 7 b), and Cdc11
was still present at the bud neck in similar amounts as in
wild-type (Fig. 7 a; data not shown). It is likely that the
other septins were also present, as septins assemble coop-
eratively. However, the septin rings in arrested ubc9 and
uba2 mutants were unlike those in wild-type preanaphase
cells in that they appeared to be discontinuous in the mid-
dle (Fig. 7 a; data not shown), almost as in cells undergoing
cytokinesis. This result may be a secondary effect of the
prolonged G2/M arrest, as we sometimes saw a similar ef-
fect in nocodazole-arrested cells, or, this observation may
suggest that SUMO conjugation prevents septins from un-
dergoing a reorganization usually associated with cytoki-
nesis prematurely.
To test whether septins are ubiquitinated or degraded
during cytokinesis, we synchronized a culture of cdc15-2
cells by incubating them at 378C, which arrests them in late
anaphase, and releasing them at 258C to allow them to
complete cytokinesis (Fig. 8). Between 30 and 50 min after
release, all the SUMO-conjugated forms of Cdc3 and
Cdc11 disappeared from these cells. However, there was
no significant reduction in the steady-state level of either
Cdc3 or Cdc11 at this point, which is consistent with the
observation by immunofluorescence microscopy that sep-
tin rings do not disappear suddenly at cytokinesis. Also, in
several different experiments, we never observed high mo-
lecular weight ubiquitinated Cdc3 species. However, we
did sometimes observe minor bands that might be degra-
dation products of Cdc11 (Fig. 8 c) and of Cdc3-HA (data
not shown). We conclude that, at most, a small fraction of
Cdc3 and Cdc11 is degraded immediately at cytokinesis.
We also tested whether the sumoylation site triple mu-
tant interacted genetically with either SUMO conjugation
pathway mutants or septin mutants. A quadruple mutant
also containing a chromosomally integrated version of the
uba2 ts10 allele grew at a range of rates similar to those
seen with the uba2 ts10 strain alone (data not shown),
which grew very poorly and was heterogeneous. Thus, the
attachment site mutations did not strongly exacerbate or
suppress the phenotypes of the uba2 ts10 mutant. How-
ever, when we crossed the sumoylation site triple mutant
to a cdc12-1 mutant, we obtained the surprising result that
Figure 7. Septins are stable in a ubc9 mutant. Strain YWO102
(ubc9) was grown to log phase in rich medium (YPD) at 258C and
shifted to 378C for the indicated period of time. a, Cdc11 was vi-
sualized by immunofluorescence microscopy using a polyclonal
antibody against Cdc11 and DNA by DAPI staining. Bar, 5 mm.
b, Whole cell lysates were analyzed by SDS-PAGE and immuno-
blotting with a polyclonal antibody against Cdc3 (top) or against
Cdc11 (bottom).The Journal of Cell Biology, Volume 147, 1999 990
the cdc3-R4,11,30,63 mutation alone was synthetically le-
thal with the cdc12-1 mutation. cdc12-1 single mutants
grow well with near normal morphology at 258C, but lose
septin rings and develop the distinctive phenotypes of sep-
tin mutants at 378C (see introduction). At 258C,  cdc3-
R4,11,30,63 cdc12-1 cells overexpressing wild-type CDC3-
HA exhibited near normal morphology (Fig. 9 a). When
CDC3-HA expression was repressed, the double mutant
developed the phenotypes of septin mutants, even at 258C,
producing branched, elongated cells and failing to undergo
cytokinesis (Fig. 9 b). This effect was not general for all
septin mutants, as the sumoylation site mutations did not
exacerbate the phenotypes of the cdc10-1 mutant (data
not shown).
Discussion
We have identified the septins Cdc3, Cdc11, and Shs1 as
the three SUMO conjugation pathway substrates that ac-
count for the most abundant sumoylated species during
yeast mitosis. Septin sumoylation was highly regulated, oc-
curring only during mitosis and only on the mother cell
side of the bud neck. We identified the major SUMO at-
tachment site Lys residues in these septins and found that
they are surrounded by a short consensus sequence that
has also been observed around the mammalian SUMO at-
tachment sites (Desterro et al., 1998; Kamitani et al.,
1998a; Mahajan et al., 1998; Matunis et al., 1998; Duprez
et al., 1999; Sternsdorf et al., 1999). Multiple copies of
SUMO could be linked to a single Cdc3 polypeptide by at-
tachment of single SUMO moieties to several different
Lys residues. We could see no evidence of SUMO chain
formation analogous to the chains formed by Ub. A mu-
tant lacking these sumoylation sites on septins grew well
and was not hypersensitive to the stress conditions tested,
but was deficient in disassembly of the septin rings after
cytokinesis. The cdc3 sumoylation site mutation also
showed synthetic lethality with the cdc12-1 mutation.
These results raise many interesting issues regarding the
regulation of SUMO conjugation and the structural and
functional alterations of the septin ring that take place
during and after cytokinesis.
While this manuscript was in preparation, another paper
was published reporting that Cdc3 is a SUMO substrate
(Takahashi et al., 1999), but there are many contradictions
between the two reports. For example, they fail to find
that Cdc11 is modified and they observe that SUMO is
found primarily as the unconjugated form, with small
amounts of low molecular weight conjugates, rather than
primarily in high molecular weight conjugates, as observed
by others (Johnson et al., 1997; Li and Hochstrasser, 1999).
These results can be explained by noting that their proto-
col for preparing yeast lysates does not, in our experience,
inhibit the isopeptidases that cleave SUMO off its sub-
strates virtually instantly when cells are lysed under native
conditions. Other groups working in this field lyse cells un-
der denaturing conditions to prevent this problem (John-
son et al., 1997; Desterro et al., 1998; Kamitani et al.,
1998b). Despite this problem, Takahashi et al. (1999) do
detect a SUMO conjugate of a Cdc3-GFP fusion protein.
Using this reporter, they make the following observations
that contradict our results: that there is only a single
SUMO-Cdc3-GFP conjugate band; that 50–100% of the
Figure 8. The steady-state levels of Cdc3 and Cdc11 do not fluc-
tuate with the cell cycle. EJY321 (cdc15-2) was grown to expo-
nential phase at 258C in synthetic (SD–URA) medium, incubated
at 378C for 3 h, cooled briefly on ice, and returned to growth at
258C. Samples taken at the indicated times after the culture was
cooled were used to make whole cell lysates, which were ana-
lyzed by SDS-PAGE and immunoblotting with a polyclonal anti-
body against Cdc3 (a and b) or against Cdc11 (c and d). b and d
are shorter exposures of a and c, respectively. Bands correspond-
ing to unmodified Cdc3 and Cdc11 are indicated. A half-open
square bracket designates high molecular weight SUMO-Cdc3
conjugates. A circle indicates a band that cross-reacts with the
anti-Cdc3 antibody. A SUMO-Cdc11 conjugate is indicated with
an arrow, and a possible proteolytic breakdown product of Cdc11
with an arrowhead. The percentage of cells in which the ac-
tin patches are polarized toward the bud neck, an indication of
cells undergoing cytokinesis, is listed over the lanes. A dash indi-
cates ,1%.
Figure 9. The cdc3 attachment site mutant is synthetically lethal
with cdc12-1. EJY323 (cdc3-R4,11,30,63 cdc12-1) carrying p315-
PGAL-CDC3-HA was grown to exponential phase at 258C in YPG
(a); or YPG-grown cells were isolated, resuspended in YPD, and
then incubated at 258C for 24 h (b). Bar, 10 mm.Johnson and Blobel SUMO Conjugation to Yeast Septins 991
total Cdc3-GFP is sumoylated (we estimate that, at most,
5% of Cdc3 or Cdc3-HA was sumoylated; Figs. 1, 2, 5, and
8); that Cdc3-GFP is sumoylated at this same high level
in a-factor-, hydroxyurea- and nocodazole-arrested cells;
that the SUMO-Cdc3-GFP conjugate persists through cell
lysis under native conditions (in our hands, Cdc3-HA is
rapidly desumoylated under these conditions; data not
shown); and that Cdc3-GFP disappears from the bud neck
upon transfer of ubc9 ts cells to the nonpermissive temper-
ature. The first four of these results also contradict other
published reports about Cdc3, where Cdc3 runs on SDS-
PAGE as a single band of the expected size for the un-
modified protein (Kim et al., 1991; Frazier et al., 1998). It
is likely that the Cdc3-GFP reporter protein is responsible
for these discrepancies. There is no evidence to support
the statement that this protein is functional, and all of
these experiments have been performed in strains also
containing the wild-type untagged genomic copy of CDC3.
The findings that the protein level of Cdc3-GFP decreases
during cytokinesis and in ubc9 ts cells at the nonpermissive
temperature contradict our results and appear to involve
technical problems with their Western blots. The most in-
teresting discrepancy is that they observe SUMO localiz-
ing to both sides of the bud neck, whereas we see it only
on the mother cell side. This observation could result from
a strain difference, but it seems more likely that their re-
sult is a phenotype of HA-SUMO overexpression.
Our results indicate that the G2/M cell cycle arrest phe-
notypes of the SUMO conjugation pathway mutants prob-
ably do not result from a reduction in septin sumoylation.
The sumoylation site triple mutant, which eliminated the
vast majority of SUMO conjugation to the septins, grew at
the same rate as wild-type and did not exhibit any cell cy-
cle arrest phenotype. Furthermore, a uba2 ts mutation did
not exacerbate the phenotype of the triple mutant, indicat-
ing that SUMO conjugation to other sites on the septins or
to some other substrate is not compensating for the loss of
the major septin sumoylation sites. It is still possible that
the minor septin sumoylation sites play a distinct essential
role for which the major sites cannot substitute. However,
we believe it is more likely that the SUMO substrates in-
volved in the essential and cell cycle-related roles of the
SUMO pathway participate in an entirely different cellu-
lar function, possibly chromosome segregation, as SMT3,
the SUMO-encoding gene, was identified as a high copy
suppressor of a mutant impaired in chromosome segrega-
tion (Meluh and Koshland, 1995).
Septin sumoylation might be controlled by the cell cy-
cle machinery through regulation of SUMO attachment,
SUMO removal, or both. It is difficult to determine the
fate of sumoylated septins at cytokinesis because of the
small fraction modified, but it is most likely that the sep-
tins are desumoylated by a SUMO-specific isopeptidase
such as Ulp1 or the similar protein Ulp2/Smt4 (Li and
Hochstrasser, 1999). In fact, one possibility is that the level
of SUMO–septin conjugates at all stages in the cell cycle
reflects a dynamic equilibrium between sumoylation and
desumoylation. We found that SUMO–septin conjugates
disappeared rapidly from nocodazole-arrested ubc9 ts
cells, but not from wild-type cells, upon shift to the non-
permissive temperature (data not shown), suggesting that
SUMO may have to be continually reattached to maintain
a constant level of septin sumoylation. Thus, septins may
be constitutively desumoylated, which would allow the
level of SUMO conjugates to be tightly regulated solely by
controlling the rate of the conjugation reaction.
Several issues depend on the structure of the septin-con-
taining neck ring, which has not been described in detail.
Purified septins form linear filaments in vitro, and the
present model for the structure of the ring holds that it
consists of parallel septin filaments running through the
bud neck parallel to the mother-bud axis (Field et al.,
1996; Frazier et al., 1998). These filaments are linked later-
ally to form the ring by an unknown mechanism involving
the Nim1-related kinases Gin4, Hsl1, and Kcc4 (Longtine
et al., 1998; Barral et al., 1999). Other proteins associate
with the septin ring in four distinct arrangements: through-
out the septin ring, on the mother cell side, on the bud
side, and in the middle between the mother cell and bud.
One model for how such regions might be established de-
rives from the fact that the mother and bud sides of the
neck ring are assembled at different points in the cell cycle
(DeMarini et al., 1997). Thus, different septin-associated
proteins could be incorporated into the different sides, es-
tablishing stable zones within the ring. Other proteins,
such as SUMO conjugation pathway enzymes, could spe-
cifically bind the asymmetrically localized proteins initially
incorporated into the different regions. A second model
relies on the potential inherent polarity of the septin fila-
ments running through the bud neck. Associated proteins
might move along the filaments in one direction or the
other until they reach the mother or bud side of the ring.
The data on septin-SUMO conjugation is less consistent
with the model where various regions are preestablished,
because it is possible for the daughter side to be sumoy-
lated. Takahashi et al. (1999) observed SUMO on both
sides of the bud neck, probably as a result of HA-SUMO
overexpression, and we also observed SUMO on both
sides of some septin rings in nocodazole-arrested cultures
(data not shown). Thus, septin sumoylation appears to be
dosage dependent, such that the mother cell side is modi-
fied first, with the daughter cell side modified when the
system is overexpressed or abnormally induced.
Another question is why such a small fraction of each of
the septins is modified. If the septin polypeptides that are
sumoylated are functionally and structurally equivalent to
the ones that are not, it would be less likely that SUMO is
blocking Lys residues against attachment of some other
modification, since these Lys residues would still be avail-
able on the vast majority of potential substrates. However,
the various septin polypeptides may not be equivalent, ei-
ther because all positions in the septin lattice may not be
equivalent structurally or because of the presence of other
posttranslational modifications. We did see variant forms
of SUMO-Cdc3 conjugates, which may bear another post-
translational modification. There did not appear to be pro-
portional amounts of a corresponding variant of unsumoy-
lated Cdc3, suggesting that the other modification may
target the same subpopulation or that one modification is
a prerequisite for the other.
The triple sumoylation site mutant is the first mutant
isolated with a defect in septin ring disassembly. We have
mentioned two models for how the triple mutant might af-
fect disassembly of the septin ring. One is that SUMO it-The Journal of Cell Biology, Volume 147, 1999 992
self promotes septin ring disassembly, and the other is that
the sumoylation-site Lys residues play some other role in
disassembly, possibly by serving as ubiquitination sites. In
the second model, SUMO might play a regulatory role by
preventing the Lys residues from taking part in the other
function. Alternatively, the other function might be com-
pletely independent from SUMO.
Any model for SUMO involvement in septin ring disas-
sembly has to explain two sets of seemingly contradictory
results. One is that SUMO is attached only to the mother
cell side of the bud neck, but the septin rings fail to be dis-
assembled in both the mother cell and in the daughter cell
(Fig. 6). The other is that SUMO–septin conjugates disap-
pear suddenly at cytokinesis, but disassembly of the septin
rings does not take place until G1 of the next cycle. The
simplest way to explain the symmetry of the phenotype is
if the SUMO-related event takes place in the center of the
septin ring. During cytokinesis, an actomyosin contractile
ring forms in the center of the septin ring (Bi et al., 1998;
Lippincott and Li, 1998b) and colocalizes with other
proteins required for contractile ring function (Epp
and Chant, 1997; Kamei et al., 1998; Lippincott and Li,
1998a,b). Contraction of the ring is triggered by an un-
known mechanism close to the same time the SUMO ring
disappears. A SUMO–septin-related event could take
place in this same region that would be required for the
complete disassembly of both the mother and daughter
cell sides of the ring. It is worth noting that the old septin
rings in the sumoylation site mutant contained much less
septin than the ring at the base of a growing bud, indicat-
ing that some disassembly did take place. Perhaps the re-
maining structure is “capped” in such a way that a post-
translational modification at the SUMO attachment sites
is required to remove it.
Either model can also explain the timing of SUMO re-
moval and septin ring disassembly. If SUMO itself pro-
motes disassembly, SUMO might be involved in an initial
event, either the SUMO-dependent association with the
septin ring of another protein that is later involved in dis-
assembly, or direct SUMO participation in a preliminary
disassembly event, whose effects only become apparent
later in the cell cycle. Using this model, it is easier to ex-
plain the fact that only a small fraction of each of the sep-
tins is modified, because a small amount of modified sep-
tin might be sufficient to attract some other protein to the
bud neck. On the other hand, the model where SUMO
prevents disassembly by inhibiting some other process is
more consistent with the timing of desumoylation, as sep-
tin ring disassembly actually starts after SUMO is re-
moved. Removal of SUMO might serve as an initiation
signal, allowing access to other proteins that trigger the
septin rearrangements that take place during and after cy-
tokinesis. However, as mentioned above, the main prob-
lem with this model is the extremely low percentage of
septin polypeptides that are actually modified. This seems
like an inefficient way to block an interaction or modifica-
tion, since .95% of all sites still would be available. An-
other key question related to this model is whether any
fraction of the septins is ubiquitinated and degraded at this
point in the cell cycle. We were unable to detect high mo-
lecular weight Ub conjugates or any dramatic reductions
in the steady-state levels of Cdc3 or Cdc11, but it is possi-
ble that a small fraction of the septins may be degraded
during cytokinesis.
Another important question is whether septin sumoyla-
tion plays other roles in initiation of anaphase, during
anaphase, or in cytokinesis. It is still possible that septin
sumoylation participates in a process carried out by two or
more partially redundant pathways, or that it is part of a
checkpoint monitoring a process that we have not per-
turbed in any of our experiments. Further analysis of
genes that interact with the septin sumoylation site mutant
should lead to a clearer picture of the role of septin
sumoylation in yeast growth.
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